See more : Radian Group Inc. (RDN) Income Statement Analysis – Financial Results
Complete financial analysis of BioMaxima S.A. (BMX.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BioMaxima S.A., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Cummins Inc. (CMI) Income Statement Analysis – Financial Results
- Edge Performance VCT Public Limited Company (EDGH.L) Income Statement Analysis – Financial Results
- Khon Kaen Sugar Industry Public Company Limited (KSL.BK) Income Statement Analysis – Financial Results
- Exclusive Networks SA (EXNWF) Income Statement Analysis – Financial Results
- Newborn Town Inc. (9911.HK) Income Statement Analysis – Financial Results
BioMaxima S.A. (BMX.WA)
About BioMaxima S.A.
BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. It supplies its products to approximately 2,000 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 2002 and is based in Lublin, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46.79M | 143.87M | 79.09M | 61.61M | 30.49M | 30.82M | 31.57M | 26.98M | 21.97M | 20.44M | 20.97M | 18.82M | 10.49M | 7.16M | 6.67M |
| Cost of Revenue | 45.82M | 89.64M | 50.10M | 37.76M | 17.53M | 17.53M | 18.47M | 15.99M | 13.17M | 11.39M | 11.90M | 10.31M | 5.46M | 3.47M | 3.22M |
| Gross Profit | 968.00K | 54.23M | 28.99M | 23.85M | 12.95M | 13.29M | 13.10M | 11.00M | 8.80M | 9.05M | 9.06M | 8.51M | 5.03M | 3.70M | 3.45M |
| Gross Profit Ratio | 2.07% | 37.69% | 36.66% | 38.71% | 42.49% | 43.13% | 41.50% | 40.76% | 40.06% | 44.27% | 43.22% | 45.24% | 47.93% | 51.63% | 51.73% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 278.30K | 476.88K | 717.59K | 668.97K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 4.72M | 3.15M | 2.58M | 3.13M | 2.56M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.61M | 17.42M | 4.72M | 3.15M | 2.58M | 3.13M | 2.56M | 572.00K | 367.26K | 6.47M | 5.44M | 5.45M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 19.38M | 10.68M | 11.07M | 9.60M | 10.11M | 7.99M | 9.57M | 7.05M | 8.41M | 7.37M | 6.70M | 3.70M | 2.89M | 2.68M |
| Operating Expenses | 1.61M | 19.38M | 15.40M | 14.22M | 12.18M | 13.24M | 12.02M | 9.57M | 7.05M | 8.41M | 7.37M | 6.70M | 3.70M | 2.89M | 2.68M |
| Cost & Expenses | 47.42M | 109.01M | 65.49M | 51.98M | 29.71M | 30.77M | 30.49M | 25.55M | 20.22M | 19.80M | 19.27M | 17.01M | 9.16M | 6.36M | 5.90M |
| Interest Income | 138.00K | 799.00K | 100.00K | 100.22K | 70.00K | 55.62K | 51.23K | 35.12K | 80.29K | 68.32K | 79.09K | 52.82K | 55.35K | 40.21K | 39.79K |
| Interest Expense | 609.00K | 475.00K | 200.00K | 311.07K | 586.31K | 328.72K | 363.08K | 112.01K | 139.39K | 204.23K | 239.70K | 331.81K | 209.05K | 77.14K | 63.22K |
| Depreciation & Amortization | 2.49M | 2.02M | 1.74M | 1.48M | 1.68M | 1.41M | 1.80M | 1.79M | 1.65M | 1.87M | 1.53M | 1.03M | 542.18K | 361.28K | 403.87K |
| EBITDA | 3.28M | 38.36M | 14.78M | 11.41M | 2.45M | 1.20M | 3.09M | 3.32M | 3.47M | 2.53M | 3.43M | 3.50M | 1.88M | 1.14M | 1.18M |
| EBITDA Ratio | 7.02% | 26.64% | 19.26% | 18.45% | 8.35% | 4.87% | 9.85% | 11.99% | 15.75% | 12.40% | 15.25% | 15.70% | 17.96% | 16.28% | 17.64% |
| Operating Income | 201.00K | 34.85M | 13.65M | 9.46M | 683.34K | -247.47K | 1.06M | 1.47M | 1.76M | 657.80K | 1.71M | 1.93M | 1.41M | 810.01K | 772.75K |
| Operating Income Ratio | 0.43% | 24.23% | 17.26% | 15.35% | 2.24% | -0.80% | 3.36% | 5.46% | 8.01% | 3.22% | 8.18% | 10.25% | 13.43% | 11.31% | 11.59% |
| Total Other Income/Expenses | -14.00K | 1.02M | -878.00K | -908.00K | -592.28K | -582.08K | -135.81K | -269.32K | -61.83K | 38.71M | -127.02K | -246.96K | -201.33K | -107.53K | -22.08K |
| Income Before Tax | 187.00K | 35.87M | 12.78M | 8.75M | 181.52K | -531.60K | 926.12K | 1.39M | 1.69M | 476.13K | 1.56M | 1.71M | 1.21M | 702.47K | 750.68K |
| Income Before Tax Ratio | 0.40% | 24.93% | 16.15% | 14.20% | 0.60% | -1.72% | 2.93% | 5.17% | 7.67% | 2.33% | 7.46% | 9.09% | 11.51% | 9.81% | 11.26% |
| Income Tax Expense | -399.00K | 6.98M | 2.53M | 1.41M | 167.52K | -69.28K | 88.30K | 167.05K | 231.04K | 21.30K | 243.90K | 334.76K | 208.30K | 163.43K | 140.31K |
| Net Income | 586.00K | 28.89M | 10.24M | 7.95M | 14.00K | -481.98K | 805.68K | 1.23M | 1.45M | 454.83K | 1.32M | 1.38M | 998.95K | 539.04K | 610.37K |
| Net Income Ratio | 1.25% | 20.08% | 12.95% | 12.90% | 0.05% | -1.56% | 2.55% | 4.55% | 6.62% | 2.23% | 6.30% | 7.31% | 9.52% | 7.52% | 9.15% |
| EPS | 0.14 | 6.68 | 2.37 | 1.93 | 0.00 | -0.13 | 0.22 | 0.29 | 0.48 | 0.15 | 0.43 | 0.49 | 0.49 | 0.26 | 0.30 |
| EPS Diluted | 0.14 | 6.48 | 2.29 | 1.85 | 0.00 | -0.13 | 0.22 | 0.29 | 0.48 | 0.15 | 0.43 | 0.49 | 0.49 | 0.26 | 0.30 |
| Weighted Avg Shares Out | 4.32M | 4.33M | 4.32M | 4.13M | 3.73M | 3.73M | 3.73M | 3.72M | 3.03M | 3.03M | 3.04M | 3.04M | 2.04M | 2.07M | 2.03M |
| Weighted Avg Shares Out (Dil) | 4.32M | 4.46M | 4.48M | 4.29M | 3.73M | 3.73M | 3.73M | 3.73M | 3.04M | 3.04M | 3.04M | 3.04M | 2.04M | 2.07M | 2.03M |
Source: https://incomestatements.info
Category: Stock Reports